Longevitytech.fund

Longevitytech.fund is a venture capital investment firm founded in 2020 and based in Prague, Czech Republic. The firm specializes in pre-seed and seed-stage investments in early-stage startups and spinoffs, focusing on sectors such as biotechnology, agtech, regenerative therapies, personalized medicine, aging diagnostics, and artificial intelligence. Longevitytech.fund distinguishes itself through close collaboration with leading scientists in aging research and rejuvenation, providing not only financial backing but also entrepreneurial assistance, networking opportunities, and commercialization support. The firm actively invests in startups across the United States, Canada, and Europe, while also offering a longevity program for its limited partners.

Bolek Kerous

Associate and Analyst

Bill Seery

Principal

Vladislav Severa Ph.D

Co-Founder and General Partner

Jan Kleindienst Ph.D

Fund Strategy and General Partner

Past deals in Czech Republic

Sampling Human

Seed Round in 2022
At XENO we believe biology speaks biology best. Many foundational problems in diagnostics and bioengineering are solvable if biology could just do more of the work. But current biotech isn’t smart enough. We are interested in changing the status quo by systematizing biologic units and constructing modular composition rules. We are a team of engineers and biologists with specialized expertise and common system goals.

Sampling Human

Convertible Note in 2021
At XENO we believe biology speaks biology best. Many foundational problems in diagnostics and bioengineering are solvable if biology could just do more of the work. But current biotech isn’t smart enough. We are interested in changing the status quo by systematizing biologic units and constructing modular composition rules. We are a team of engineers and biologists with specialized expertise and common system goals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.